| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $24.2B | $12.8B |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| R&D Expense | — | — |
| SG&A Expense | — | — |
| Operating Income | $7.0B | $7.6B |
| Net Income | $5.6B | $6.4B |
| EPS (Basic) | $35.83 | $42.45 |
| EPS (Diluted) | $35.31 | $42.01 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $170.0B | $138.6B |
| Current Assets | — | — |
| Cash & Equivalents | $11.5B | $12.8B |
| Total Liabilities | $108.5B | $89.3B |
| Current Liabilities | — | — |
| Stockholders' Equity | $55.9B | $47.5B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $3.9B | $5.0B |
| Investing Cash Flow | $-4.4B | $-3.0B |
| Capital Expenditures | $0.4B | $0.3B |
| Financing Cash Flow | $-1.1B | $2.2B |